These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 19958824)
1. Bioadhesion and oral absorption of enoxaparin nanocomplexes. Sun W; Mao S; Wang Y; Junyaprasert VB; Zhang T; Na L; Wang J Int J Pharm; 2010 Feb; 386(1-2):275-81. PubMed ID: 19958824 [TBL] [Abstract][Full Text] [Related]
2. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin. Sun W; Mao S; Mei D; Kissel T Eur J Pharm Biopharm; 2008 Jun; 69(2):417-25. PubMed ID: 18294825 [TBL] [Abstract][Full Text] [Related]
3. Exploration of hydrophobic modification degree of chitosan-based nanocomplexes on the oral delivery of enoxaparin. Wang L; Li L; Sun Y; Tian Y; Li Y; Li C; Junyaprasert VB; Mao S Eur J Pharm Sci; 2013 Nov; 50(3-4):263-71. PubMed ID: 23896170 [TBL] [Abstract][Full Text] [Related]
4. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
5. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation. Paliwal R; Paliwal SR; Agrawal GP; Vyas SP Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712 [TBL] [Abstract][Full Text] [Related]
6. Uptake, transport and peroral absorption of fatty glyceride grafted chitosan copolymer-enoxaparin nanocomplexes: influence of glyceride chain length. Wang L; Sun Y; Shi C; Li L; Guan J; Zhang X; Ni R; Duan X; Li Y; Mao S Acta Biomater; 2014 Aug; 10(8):3675-85. PubMed ID: 24814881 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of chitosan graft glyceryl monooleate as peroral delivery carrier of enoxaparin. Wang L; Li L; Sun Y; Ding J; Li J; Duan X; Li Y; Junyaprasert VB; Mao S Int J Pharm; 2014 Aug; 471(1-2):391-9. PubMed ID: 24882036 [TBL] [Abstract][Full Text] [Related]
8. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles. Jintapattanakit A; Junyaprasert VB; Mao S; Sitterberg J; Bakowsky U; Kissel T Int J Pharm; 2007 Sep; 342(1-2):240-9. PubMed ID: 17597316 [TBL] [Abstract][Full Text] [Related]
9. Chitosan based polymer-lipid hybrid nanoparticles for oral delivery of enoxaparin. Dong W; Wang X; Liu C; Zhang X; Zhang X; Chen X; Kou Y; Mao S Int J Pharm; 2018 Aug; 547(1-2):499-505. PubMed ID: 29859924 [TBL] [Abstract][Full Text] [Related]
10. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery. Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318 [TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Makhlof A; Tozuka Y; Takeuchi H Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939 [TBL] [Abstract][Full Text] [Related]
12. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies. Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808 [TBL] [Abstract][Full Text] [Related]
13. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation. Fan B; Xing Y; Zheng Y; Sun C; Liang G Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290 [TBL] [Abstract][Full Text] [Related]
14. Delivery of protein drugs using nanoparticles self-assembled from dextran sulfate and quaternized chitosan. Shu S; Zhang X; Wu Z; Wang Z; Li C J Control Release; 2011 Nov; 152 Suppl 1():e170-2. PubMed ID: 22195830 [No Abstract] [Full Text] [Related]
15. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability. Quan P; Shi K; Piao H; Piao H; Liang N; Xia D; Cui F Int J Pharm; 2012 Jul; 430(1-2):366-71. PubMed ID: 22531846 [TBL] [Abstract][Full Text] [Related]
16. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Yin L; Ding J; He C; Cui L; Tang C; Yin C Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735 [TBL] [Abstract][Full Text] [Related]
17. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606 [TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439 [TBL] [Abstract][Full Text] [Related]
20. Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats. Mei D; Mao S; Sun W; Wang Y; Kissel T Eur J Pharm Biopharm; 2008 Nov; 70(3):874-81. PubMed ID: 18656537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]